Literature DB >> 2685658

'Transient monocular blindness' versus 'amaurosis fugax'.

C M Fisher1.   

Abstract

The term "transient monocular blindness" is gradually being replaced with "amaurosis fugax," which has a less precise connotation. The history of this change is traced herein.

Entities:  

Mesh：

Year:  1989        PMID： 2685658     DOI： 10.1212/wnl.39.12.1622

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  8 in total

1.  Eye syndromes and the neuro-ophthalmology of stroke.

Authors:  Valérie Biousse; Nancy J Newman
Journal:  Handb Clin Neurol       Date:  2009

2.  Carotid artery stenosis, an underestimated cause of stroke recurrence in patients with ischaemic monocular visual loss.

Authors:  S F Cheng; A Zarkali; T Richards; R Simister; A Chandratheva
Journal:  Ann R Coll Surg Engl       Date:  2019-06-03       Impact factor: 1.891

3.  Vascular neuro-ophthalmology.

Authors:  Cédric Lamirel; Nancy J Newman; Valérie Biousse
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

4.  [Vascular transient monocular visual loss].

Authors:  C Cochard-Marianowski; C Lamirel; V Biousse
Journal:  J Fr Ophtalmol       Date:  2009-12       Impact factor: 0.818

5.  Patterns of non-embolic transient monocular visual field loss.

Authors:  Axel Petzold; Niaz Islam; G T Plant
Journal:  J Neurol       Date:  2013-04-06       Impact factor: 4.849

6.  Optic neuritis presenting with amaurosis fugax.

Authors:  Amer M Awad; Bachir Estephan; Worthy Warnack; Olaf Stüve
Journal:  J Neurol       Date:  2009-09-02       Impact factor: 4.849

Review 7.  Ophthalmic masquerades of the atherosclerotic carotids.

Authors:  Anupriya Arthur; Anika Alexander; Simerpreet Bal; Ajith Sivadasan; Sanjith Aaron
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

8.  Transient monocular blindness and the risk of vascular complications according to subtype: a prospective cohort study.

Authors:  Eline J Volkers; Richard C J M Donders; Peter J Koudstaal; Jan van Gijn; Ale Algra; L Jaap Kappelle
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.